Junjie X. Hang
Xinglong Road 19
Changzhou, 213000, China
Changzhou, 213000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
PLOD1 Drives Head and Neck Squamous Cell Carcinoma Progression Through P4HA2-Mediated Activation of the FAK/PI3K/AKT/mTOR Axis.
Journal: Journal of cellular and molecular medicine
Published: February 19, 2026
Impact of immunochemotherapy administration sequence on overall survival in advanced esophageal and gastric cancers: a propensity score-matched multicenter analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: June 19, 2025
Revisiting the starting age of colorectal cancer screening for the average-risk Asian population: a cost-effectiveness analysis.
Journal: Gastrointestinal endoscopy
Published: January 03, 2025
Expression of HECTD2 predicts peritoneal metastasis of gastric cancer and reconstructs immune microenvironment.
Journal: Cancer cell international
Published: July 07, 2024
Pan-cancer analysis of Sp1 with a focus on immunomodulatory roles in gastric cancer.
Journal: Cancer cell international
Published: June 23, 2024
Evaluation of an Electronic Application for Enhancing Medication Adherence Among Hypertensive Patients: A Qualitative Research Based on Consolidated Framework for Implementation Research (CFIR).
Journal: Health science reports
Published: May 17, 2024
Perceptions and Attitudes Toward Utilizing a Non-Invasive Biomarker for Colorectal Cancer Screening: A Qualitative Study.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 10, 2024
The Cost-Effectiveness of a Multi-Target Stool DNA-Based Screening (COLOTECT), FIT, Colonoscopy and No Screening for Colorectal Cancer.
Journal: Cancer reports (Hoboken, N.J.)
Published: March 08, 2024
Development and Validation of a Radiomics Nomogram for Liver Metastases Originating from Gastric and Colorectal Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: August 08, 2023
Association of the CD4+/CD8+ ratio with response to PD-1 inhibitor-based combination therapy and dermatological toxicities in patients with advanced gastric and esophageal cancer.
Journal: International immunopharmacology
Published: May 22, 2023
Last Updated: 09/26/2026